Next Article in Journal
Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient® in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06)
Next Article in Special Issue
Immune System Alterations in Multiple Myeloma: Molecular Mechanisms and Therapeutic Strategies to Reverse Immunosuppression
Previous Article in Journal
Molecular and Clinical Premises for the Combination Therapy Consisting of Radiochemotherapy and Immunotherapy in Non-Small Cell Lung Cancer Patients
Previous Article in Special Issue
The Immune Microenvironment in Multiple Myeloma: Friend or Foe?
 
 
Review

Article Versions Notes

Cancers 2021, 13(6), 1221; https://doi.org/10.3390/cancers13061221
Action Date Notes Link
article xml file uploaded 11 March 2021 09:35 CET Original file -
article xml uploaded. 11 March 2021 09:35 CET Update -
article pdf uploaded. 11 March 2021 09:35 CET Version of Record https://www.mdpi.com/2072-6694/13/6/1221/pdf-vor
article html file updated 11 March 2021 09:37 CET Original file -
article xml file uploaded 18 March 2021 04:45 CET Update -
article xml uploaded. 18 March 2021 04:45 CET Update https://www.mdpi.com/2072-6694/13/6/1221/xml
article pdf uploaded. 18 March 2021 04:45 CET Updated version of record https://www.mdpi.com/2072-6694/13/6/1221/pdf
article html file updated 18 March 2021 04:46 CET Update -
article html file updated 25 July 2022 07:08 CEST Update https://www.mdpi.com/2072-6694/13/6/1221/html
Back to TopTop